Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leon, L. L.
Right arrow Articles by Durán, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leon, L. L.
Right arrow Articles by Durán, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 449-450
© 2001 The British Society for Antimicrobial Chemotherapy

Correspondence

Antileishmanial activity of the violacein extracted from Chromobacterium violaceum

L. L. Leona, C. C. Mirandaa, A. O. De Souzab,c and N. Duránb,c,*

a Department of Immunology, Instituto Oswaldo Cruz, FIOCRUZ RJ; b Instituto de Química, Biological Chemistry Laboratory, Universidade Estadual de Campinas, SP; c Department of Biochemistry and Immunology, Medicine Faculty Riberão Preto, Universidade de São Paulo, SP; d NCA, Universidade de Mogi das Cruzes, Mogi das Cruzes, SP, Brazil

Sir,

Leishmaniasis is a disfiguring and sometimes fatal protozoan disease, affecting more than 12 million people worldwide. The drugs used to treat the disease were developed more than 50 years ago and are potentially toxic. Leishmania amazonensis is very common in Brazil and is associated with different forms of the disease, . . . [Full Text of this Article]

Acknowledgements

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. C. P. Lopes, Y. C. Blanco, G. Z. Justo, P. A. Nogueira, F. L. S. Rodrigues, U. Goelnitz, G. Wunderlich, G. Facchini, M. Brocchi, N. Duran, et al.
Violacein Extracted from Chromobacterium violaceum Inhibits Plasmodium Growth In Vitro and In Vivo
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2149 - 2152.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. Ryan, C. J. Balibar, K. E. Turo, C. T. Walsh, and C. L. Drennan
The Violacein Biosynthetic Enzyme VioE Shares a Fold with Lipoprotein Transporter Proteins
J. Biol. Chem., March 7, 2008; 283(10): 6467 - 6475.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. L. Kodach, C. L. Bos, N. Duran, M. P. Peppelenbosch, C. V. Ferreira, and J. C.H. Hardwick
Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells
Carcinogenesis, March 1, 2006; 27(3): 508 - 516.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. V. Ferreira, C. L. Bos, H. H. Versteeg, G. Z. Justo, N. Duran, and M. P. Peppelenbosch
Molecular mechanism of violacein-mediated human leukemia cell death
Blood, September 1, 2004; 104(5): 1459 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Brazilian National Genome Project Consortium:, A. T. Ribeiro de Vasconcelos, D. F. de Almeida, M. Hungria, C. T. Guimaraes, R. V. Antonio, F. C. Almeida, L. G. P. de Almeida, R. de Almeida, J. A. Alves-Gomes, et al.
The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability
PNAS, September 30, 2003; 100(20): 11660 - 11665.
[Abstract] [Full Text] [PDF]